ASX Critical Minerals Processing Sector Deep Dive
Australia’s push into critical minerals processing is no longer just a policy narrative, it is becoming a capital markets story that is starting to show…
Most Popular
Grow your wealth. Expand your knowledge. Leverage strategic insight.
The Investor Standard delivers world-class market analysis, stock recommendations, and exclusive insights to help you make smarter investment decisions and stay ahead of the market.
The new wave of ex dividend stocks in April, where income still matters in a volatile market
A fresh wave of income April 2026 is shaping up as one of the busier ex dividend periods of the…
The War Premium Is Cracking, but the Market Still Doesn’t Trust Peace
What falling oil is really telling markets.
Dividend Portfolio Series: 5 Growth Dividend Stocks You Should Own in 2026
1. Apple Inc.: NASDAQ Apple Inc. is viewed as a strong dividend stock because it pairs dependable income with steady…
SpaceX, OpenAI and Anthropic Could Define the Next IPO Cycle, and Test the Limits of the AI Boom
The next great IPO wave The next IPO cycle is shaping as something bigger than a typical listing window, with…
Markets
Inflation fears are rising fast, but the bond market is not buying the panic
What Australia's bond market is signalling.
Highlighted Insights
An Outlook on ASX: Ramsay Health Care (RHC)
Business Summary & Overview Ramsay Health Care is a prominent international hospital operator offering acute care, surgical services, mental health support, and specialised medical treatments.…
Value’s revenge, why boring, cash rich businesses may be the surprise winners of 2026
The shift back toward value is getting harder to ignore For years, owning “boring” businesses felt like sitting on the…
ASX Weekly Market Wrap
A Bounce, But Not a Clean Recovery Australian equities finally broke their losing streak, with the ASX 200 finishing the…
What Caused the Meta Layoffs?
Meta’s layoffs in recent years have not only reshaped its internal organisation but also influenced wider expectations around job stability…
Market Outlook: The Shift From Soft Landing to Geopolitical Risk Premium
Oil, inflation and a volatile week ahead.
Featured Investments (Stock Picks)
ASX Weekly Market Wrap
Markets Are Rolling Over, But the Rotation Matters More Australian equities have now extended their…
NEXTDC (ASX: NXT) Investment Analysis
Wiring Australia for the AI Supercycle NEXTDC sits at the centre of one of the…
Unlock Smarter Investing
Gain access to independent ASX insights, exclusive stock picks, and in-depth research trusted by founders, boards, and investors.
ASX Stocks in Focus: Five Quality Names Beyond the Usual Trade
Positioning portfolios beyond momentum.
ASX Weekly Market Wrap
RBA Rate Hike Triggers Tech Selloff Market overview The ASX weekly market wrap for the…
Investor Insights, Delivered
Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.
Explore More Insights
IperionX Short Seller Allegations: Why Investors See Opportunity in the Fallout
A Critical Minerals Darling Under Fire The short-seller spotlight has swung into IperionX, the U.S. based, ASX-listed titanium producer championed…
How ESG Investing is Driving Venture Capital Decisions Down Under
In recent years, Environmental, Social, and Governance (ESG) considerations have become pivotal in shaping venture capital (VC) investment strategies in…
ASX Diverges on Shocks: Banks Prop, Health & Tech Slide as Domino’s Pops, CSL Sinks
ASX Diverges on Shocks ASX diverges on shocks as headline-driven moves overwhelm the Wall Street lead. By late morning. the…
ETF Investing in Australia: A Practical Guide for Busy Investors
Exchange traded funds have become the default building blocks for Australian portfolios because they provide broad diversification, transparent rules, and…
GlenTinto and the Copper Crunch: BHP Feels the Pressure
The mining sector has been rocked by the news that Rio Tinto and Glencore have revived talks on a $300…
Investment Analysis: Mesoblast Ltd (ASX: MSB)
Business Summary Mesoblast Limited specializes in developing allogeneic, “off‑the‑shelf” cellular medicines designed to treat severe inflammatory conditions. The company’s late‑stage…
Socials
Monthly Investor Memo
Delivered Monthly - 2026